Cargando…
Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial
BACKGROUND: Botulinum toxin type A is widely used for treating spasticity. Neuronox (Neu-BoNT/A), a newly manufactured botulinum toxin a, has not yet been investigated for its efficacy and safety in the treatment of post-stroke upper limb spasticity. OBJECTIVE: We evaluated the efficacy and safety o...
Autores principales: | Seo, Han Gil, Paik, Nam-Jong, Lee, Shi-Uk, Oh, Byung-Mo, Chun, Min Ho, Kwon, Bum Sun, Bang, Moon Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452301/ https://www.ncbi.nlm.nih.gov/pubmed/26030192 http://dx.doi.org/10.1371/journal.pone.0128633 |
Ejemplares similares
-
Comparison of Safety and Efficacy of Botox and Neuronox in the Management of Benign Essential Blepharospasm: A Split-face Study
por: Sane, Sayali, et al.
Publicado: (2019) -
Hematuria following Botox treatment for upper limb spasticity: a case report
por: Lo, Tony CT, et al.
Publicado: (2015) -
Feasibility of Video Clip Analysis on Effect of Botulinum Toxin-A Injection for Post-Stroke Upper Limb Spasticity
por: Kim, Woo-Jin, et al.
Publicado: (2013) -
Treatment of adult spasticity with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Esquenazi, Alberto, et al.
Publicado: (2023) -
Safety and efficacy of MT10107 in post-stroke upper limb spasticity treatment: A phase I randomized controlled trial
por: Lee, Junekyung, et al.
Publicado: (2022)